ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Recommended dose modification for neuropathic pain and/or peripheral sensory neuropathy during treatment with bortezomib (Velcade)

Recommended dose modification for neuropathic pain and/or peripheral sensory neuropathy during treatment with bortezomib (Velcade)
Severity of symptoms Dose modification
Grade 1 (asymptomatic, loss of deep tendon reflexes or paresthesia without pain or loss of function) No action needed
Grade 2 (interfering with function but not activities of daily living) or Grade 1 with pain Reduce dose to 1 mg/m2
Grade 3 (interfering with activities of daily living) or Grade 2 with pain Withhold until toxicity resolved, may reinitiate at 0.7 mg/m2 once weekly
Grade 4 (life-threatening, disabling, eg, paralysis) Discontinue therapy
Graphic 70033 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟